Ecor1 Capital, Llc, Ten Percent Owner at Eiger Biopharmaceuticals, holds 7.79M shares in AnaptysBio (Ticker: ANAB), holds 13.44M shares in Zymeworks (Ticker: ZYME), holds 3.85M shares in Voyager Therapeutics (Ticker: VYGR). Most recently, Ecor1 Capital, Llc Bought ― shares of AnaptysBio on Aug 16, 2024 for an estimated value of 10.00M.
Ecor1 Capital, Llc latest transaction was an Informative Buy of $10.00M.
What was Ecor1 Capital, Llc's most profitable transaction?
Ecor1 Capital, Llc’s most profitable transaction was an Informative Buy of PRTA stock on May 9, 2022. The return on the trade was 180.00%.
What is Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals?
Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.